Provided by Tiger Fintech (Singapore) Pte. Ltd.

ACADIA Pharmaceuticals

22.28
-0.2800-1.24%
Post-market: 22.280.00000.00%16:23 EDT
Volume:889.40K
Turnover:19.93M
Market Cap:3.73B
PE:16.28
High:22.84
Open:22.67
Low:22.09
Close:22.56
Loading ...

ACADIA Pharmaceuticals Inc : Leerink Partners Raises Target Price to $32 From $28

THOMSON REUTERS
·
11 Jul

RBC Capital Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
08 Jul

RBC Lifts Price Target on ACADIA Pharmaceuticals to $39 From $38, Keeps Outperform Rating

MT Newswires Live
·
07 Jul

Acadia Pharmaceuticals Announces Inducement Awards for New Employees Under 2024 Plan

Reuters
·
04 Jul

ACADIA Pharmaceuticals (ACAD) Gets a Buy from TD Cowen

TIPRANKS
·
27 Jun

Acadia Pharmaceuticals Stock Price Undervalues Potential Market Opportunity of Nuplazid, Daybue, RBC Says

MT Newswires Live
·
26 Jun

Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $22 From $19, Maintains Perform Rating

MT Newswires Live
·
26 Jun

ACADIA Pharmaceuticals, Inc. : Oppenheimer Raises Target Price to $22 From $19

THOMSON REUTERS
·
26 Jun

H.C. Wainwright Reaffirms Their Buy Rating on ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
26 Jun

ACADIA Pharmaceuticals Price Target Maintained With a $30.00/Share by Needham

Dow Jones
·
26 Jun

ACADIA Pharmaceuticals: Hold Rating Amid Strategic R&D Focus and Competitive Challenges

TIPRANKS
·
26 Jun

U.S. RESEARCH ROUNDUP-Aerovironment, Cisco, Dell Technologies

Reuters
·
26 Jun

BRIEF-Acadia Pharmaceuticals expects To Deliver Over $1 Billion In Net Sales in FY2025

Reuters
·
25 Jun

ACADIA Pharmaceuticals Inc FY2025 REV View $1.06 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
25 Jun

ACADIA Pharmaceuticals Inc: on Track to Deliver Over $1 Bln in Net Sales This Year

THOMSON REUTERS
·
25 Jun

ACADIA Pharmaceuticals Announces Upcoming Phase 2 and 3 Clinical Trials for Neurological and Rare Disease Treatments, Aiming for Key Study Readouts by 2027

Reuters
·
25 Jun

ACADIA Pharmaceuticals Is Maintained at Outperform by RBC Capital

Dow Jones
·
23 Jun

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Select Medical (SEM) and ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
23 Jun

RBC Raises Price Target on ACADIA Pharmaceuticals to $38 From $26, Keeps Outperform Rating

MT Newswires Live
·
23 Jun

ACADIA Pharmaceuticals Inc : RBC Raises Target Price to $38 From $26

THOMSON REUTERS
·
23 Jun